189 related articles for article (PubMed ID: 33838651)
1. PET/MR imaging for the evaluation of cervical cancer during pregnancy.
Ishiguro T; Nishikawa N; Ishii S; Yoshihara K; Haino K; Yamaguchi M; Adachi S; Watanabe T; Soeda S; Enomoto T
BMC Pregnancy Childbirth; 2021 Apr; 21(1):288. PubMed ID: 33838651
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer.
Park W; Park YJ; Huh SJ; Kim BG; Bae DS; Lee J; Kim BH; Choi JY; Ahn YC; Lim DH
Jpn J Clin Oncol; 2005 May; 35(5):260-4. PubMed ID: 15886267
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of parametrial infiltration in cervical cancer with voxel-based segmentation of integrated
Wang T; Sun H; Han F; Sun W; Chen Z
Eur J Radiol; 2019 Sep; 118():147-152. PubMed ID: 31439234
[TBL] [Abstract][Full Text] [Related]
5. Preoperative PET/CT FDG standardized uptake value of pelvic lymph nodes as a significant prognostic factor in patients with uterine cervical cancer.
Chung HH; Cheon GJ; Kang KW; Kim JW; Park NH; Song YS
Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):674-81. PubMed ID: 24233005
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
Pinker K; Andrzejewski P; Baltzer P; Polanec SH; Sturdza A; Georg D; Helbich TH; Karanikas G; Grimm C; Polterauer S; Poetter R; Wadsak W; Mitterhauser M; Georg P
PLoS One; 2016; 11(5):e0155333. PubMed ID: 27167829
[TBL] [Abstract][Full Text] [Related]
7. Comparison of
Sarabhai T; Schaarschmidt BM; Wetter A; Kirchner J; Aktas B; Forsting M; Ruhlmann V; Herrmann K; Umutlu L; Grueneisen J
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):67-76. PubMed ID: 28840302
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic efficiency of whole-body
Steiner A; Narva S; Rinta-Kiikka I; Hietanen S; Hynninen J; Virtanen J
Cancer Imaging; 2021 Jan; 21(1):16. PubMed ID: 33482909
[TBL] [Abstract][Full Text] [Related]
9. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA
Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068
[TBL] [Abstract][Full Text] [Related]
10. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients.
Kim SK; Choi HJ; Park SY; Lee HY; Seo SS; Yoo CW; Jung DC; Kang S; Cho KS
Eur J Cancer; 2009 Aug; 45(12):2103-9. PubMed ID: 19403303
[TBL] [Abstract][Full Text] [Related]
11. Primary epithelioid trophoblastic tumor with a synchronous breast carcinoma detected only with FDG-PET/CT Scan.
Kara T; Ozcan Kara P; Baba F; Celik C; Kara Gedik G
Rev Esp Med Nucl; 2011; 30(6):368-71. PubMed ID: 21440960
[TBL] [Abstract][Full Text] [Related]
12. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
[TBL] [Abstract][Full Text] [Related]
14. The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers.
Nakasone Y; Inoue T; Oriuchi N; Takeuchi K; Negishi A; Endo K; Mogi K
Ann Nucl Med; 2001 Dec; 15(6):505-12. PubMed ID: 11831398
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.
Botsikas D; Kalovidouri A; Becker M; Copercini M; Djema DA; Bodmer A; Monnier S; Becker CD; Montet X; Delattre BM; Ratib O; Garibotto V; Tabouret-Viaud C
Eur Radiol; 2016 Jul; 26(7):2297-307. PubMed ID: 26477029
[TBL] [Abstract][Full Text] [Related]
16. Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer.
Chung HH; Nam BH; Kim JW; Kang KW; Park NH; Song YS; Chung JK; Kang SB
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1467-73. PubMed ID: 20352210
[TBL] [Abstract][Full Text] [Related]
17. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
[TBL] [Abstract][Full Text] [Related]
18. (18)F-FDG PET/CT can correct the clinical stages and predict pathological parameters before operation in cervical cancer.
Yang Z; Xu W; Ma Y; Liu K; Li Y; Wang D
Eur J Radiol; 2016 May; 85(5):877-84. PubMed ID: 27130046
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of FDG PET-CT on the management of patients with locally advanced cervical carcinoma.
Fleming S; Cooper RA; Swift SE; Thygesen HH; Chowdhury FU; Scarsbrook AF; Patel CN
Clin Radiol; 2014 Dec; 69(12):1235-43. PubMed ID: 25439186
[TBL] [Abstract][Full Text] [Related]
20. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
Cancer; 2010 Mar; 116(6):1469-75. PubMed ID: 20108309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
